![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Guangning Wang, Ran Zhang, Chuan Li & Aiping Chen. (2022) Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 7601-7608.
Read now
Read now
Cihan Karadağ, Bertan Akar, Gökçenur Gönenç, Reyhan Aslancan, Nagihan Yılmaz & Eray Çalışkan. (2020) Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. The Journal of Maternal-Fetal & Neonatal Medicine 33:11, pages 1934-1939.
Read now
Read now
Articles from other publishers (86)
Akbayan Turesheva, Gulzhanat Aimagambetova, Talshyn Ukybassova, Aizada Marat, Perizat Kanabekova, Lyazzat Kaldygulova, Ainur Amanzholkyzy, Svetlana Ryzhkova, Anastassiya Nogay, Zaituna Khamidullina, Aktoty Ilmaliyeva, Wassim Y. Almawi & Kuralay Atageldiyeva. (2023) Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box. Journal of Clinical Medicine 12:12, pages 4074.
Crossref
Crossref
Samaneh Abdolmohammadi-Vahid, Leili Aghebati-Maleki, Javad Ahmadian-Heris, Shahla Danaii & Mehdi Yousefi. 2023. IVF Technologies and Infertility - Current Practices and New Perspectives. IVF Technologies and Infertility - Current Practices and New Perspectives.
Margherita Scarrone, Valentina Canti, Valeria Stella Vanni, Sara Bordoli, Federica Pasi, Lavinia Quaranta, Roberta Erra, Rebecca De Lorenzo, Susanna Rosa, Maria Teresa Castiglioni, Massimo Candiani & Patrizia Rovere-Querini. (2022) Treating unexplained recurrent pregnancy loss based on lessons learned from obstetric antiphospholipid syndrome and inherited thrombophilia: A propensity-score adjusted retrospective study. Journal of Reproductive Immunology 154, pages 103760.
Crossref
Crossref
Yan Chen, Tingting Wang, Xiaoling Liu, Changxiang Ye, Dexiu Xing, Rong Wu, Fang Li & Lizhang Chen. (2022) Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research 48:8, pages 2134-2150.
Crossref
Crossref
Yan Huang, Fei Li, Changhong Li & Xueli Liao. (2022) Efficacy of Low Molecular Weight Heparin in Preventing Perinatal Venous Thrombosis: A Meta-Analysis. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Crossref
Sara Zullino, Sara Clemenza, Federico Mecacci & Felice Petraglia. (2021) Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta. Reproductive Sciences 29:5, pages 1414-1423.
Crossref
Crossref
Monica Cruz-Lemini, Juan Carlos Vázquez, Johana Ullmo & Elisa Llurba. (2022) Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 226:2, pages S1126-S1144.e17.
Crossref
Crossref
Geneviève Genest, Walaa Almasri, Shorooq Banjar, Coralie Beauchamp, William Buckett, Frederick Dzineku, Ezgi Demirtas, Phil Gold, Michael H. Dahan, Wael Jamal, Isaac Jacques Kadoch, Louise Lapensée, Neal Mahutte, Pierre Miron, Camille Sylvestre, Togas Tulandi, Ciriaco A. Piccirillo & Carl A. Laskin. (2022) Immunotherapy for recurrent pregnancy loss: a reappraisal. F&S Reviews 3:1, pages 24-41.
Crossref
Crossref
Xiaoli Yan, Dan Wang, Ping Yan & Hongyu Li. (2022) Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 268, pages 22-30.
Crossref
Crossref
M. G. Nikolaeva, N. N. Yasafova, A. P. Momot, M. S. Zainulina & I. A. Taranenko. (2021) Low molecular weight heparin prophylaxis for placenta-mediated complications in women with F2G20210A mutation. Russian journal of hematology and transfusiology 66:2, pages 231-241.
Crossref
Crossref
P. Merviel, J. Hannigsberg, C. Tremouilhac, S. Herrmann, A.H. Saliou, P.F. Dupré, C. De Moreuil, E. Pasquier, E. Le Moigne & F. Couturaud. (2021) Abortos espontáneos recurrentes. EMC - Ginecología-Obstetricia 57:3, pages 1-17.
Crossref
Crossref
Alessandra Bettiol, Laura Avagliano, Niccolò Lombardi, Giada Crescioli, Giacomo Emmi, Maria Letizia Urban, Gianni Virgili, Claudia Ravaldi & Alfredo Vannacci. (2021) Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta‐Analysis. Clinical Pharmacology & Therapeutics 110:1, pages 189-199.
Crossref
Crossref
Ben W. Mol. (2021) Letter to the Editor Regarding Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-analysis. Are All the Underlying Data True?. Advances in Therapy 38:5, pages 2757-2758.
Crossref
Crossref
Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Maria Stamou, Athina Spanoudaki & Emmanouil Spanoudakis. (2021) Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature. Journal of Gynecology Obstetrics and Human Reproduction 50:4, pages 101935.
Crossref
Crossref
Philippa Middleton, Emily Shepherd & Judith C Gomersall. (2021) Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Crossref
Fangfei Jiang, Xiuying Hu, Kang Jiang, Hongxia Pi, Qiyao He & Xinmin Chen. (2021) The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics and Gynecology 60:1, pages 1-8.
Crossref
Crossref
Shaoying Yang, Ruoning Ni, Yikang Lu, Suli Wang, Feng Xie, Chunyan Zhang & Liangjing Lu. (2020) A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial. Trials 21:1.
Crossref
Crossref
Jie Li, Yue‐hua Gao, Lin Xu & Zeng‐yan Li. (2020) Meta‐analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion. International Journal of Gynecology & Obstetrics 151:1, pages 23-32.
Crossref
Crossref
I. Aslan, S. Ozyigit, L.T. Paul, O. Tosun & P. Tulay. (2020) Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages?. Journal of Reproductive Immunology 141, pages 103172.
Crossref
Crossref
Esmée M Bordewijk, Rui Wang, Lisa M. Askie, Lyle C. Gurrin, Jim G. Thornton, Madelon van Wely, Wentao Li & Ben W. Mol. (2020) Data integrity of 35 randomised controlled trials in women’ health. European Journal of Obstetrics & Gynecology and Reproductive Biology 249, pages 72-83.
Crossref
Crossref
Shafat Ali, Sabhiya Majid, Md. Niamat Ali & Shahnaz Taing. (2020) Evaluation of T cell cytokines and their role in recurrent miscarriage. International Immunopharmacology 82, pages 106347.
Crossref
Crossref
Barry Jacobson, Virendra Rambiritch, Dara Paek, Tobias Sayre, Poobalan Naidoo, Jenny Shan & Rory Leisegang. (2019) Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Advances in Therapy 37:1, pages 27-40.
Crossref
Crossref
Tao Lin, Yumei Chen, Xuanyu Cheng, Na Li & Xiaolu Sheng. (2019) Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies. European Journal of Obstetrics & Gynecology and Reproductive Biology 234, pages 53-57.
Crossref
Crossref
D.E. Lowry, D.J. Corsi, R.R. White, M. Guo, A. Lanes, G. Smith, M. Rodger, S.W. Wen, M. Walker & L. Gaudet. (2019) Association between prophylactic low‐molecular‐weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort. Journal of Thrombosis and Haemostasis 17:2, pages 345-349.
Crossref
Crossref
Shannon M. Bates. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
665
694
.
Anita Rajasekhar & Marc Zumberg. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
300
337
.
Aleena M Wojcieszek, Emily Shepherd, Philippa Middleton, Zohra S Lassi, Trish Wilson, Margaret M Murphy, Alexander EP Heazell, David A Ellwood, Robert M Silver & Vicki Flenady. (2018) Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Lennart Blomqvist, Margareta Hellgren & Annika Strandell. (2018) Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 97:11, pages 1365-1372.
Crossref
Crossref
M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot & N. N. Yasafova. (2018) Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype). Obstetrics, Gynecology and Reproduction 12:2, pages 21-31.
Crossref
Crossref
Emma Rasmark Roepke, Margareta Hellgren, Ragnhild Hjertberg, Lennart Blomqvist, Leif Matthiesen, Emir Henic, Sujata Lalitkumar & Annika Strandell. (2018) Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses. Acta Obstetricia et Gynecologica Scandinavica 97:8, pages 921-941.
Crossref
Crossref
Sha Lv, Jing Yu & Xiaoxiao Xu. (2018) A comparison of effectiveness among frequent treatments of recurrent spontaneous abortion: A Bayesian network meta-analysis. American Journal of Reproductive Immunology 80:1, pages e12856.
Crossref
Crossref
Philippe Merviel, Rosalie Cabry, Emmanuelle Lourdel, Segolene Lanta, Carole Amant, Henri Copin & Moncef Benkhalifa. (2017) Comparison of two preventive treatments for patients with recurrent miscarriages carrying a C677T methylenetetrahydrofolate reductase mutation: 5-year experience. Journal of International Medical Research 45:6, pages 1720-1730.
Crossref
Crossref
Meital Shlomo, Rafael Gorodischer, Sharon Daniel, Arnon Wiznitzer, Ilan Matok, Boris Fishman, Gideon Koren & Amalia Levy. (2017) The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study. Drug Safety 40:11, pages 1147-1155.
Crossref
Crossref
Omar M. Shaaban, Ahmed M. Abbas, Kamal M. Zahran, Mohamed M. Fathalla, Mohamed A. Anan & Safwat A. Salman. (2016) Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial. Clinical and Applied Thrombosis/Hemostasis 23:6, pages 567-572.
Crossref
Crossref
M.V. Galaiko, O.V. Rybina, M.S. Litvinenko, Yu.V. Klimov, B.Yu. Al'tshuler & A.V. Gubkin. (2017) Thrombophilia and Pregnancy. Clinical oncohematology 10:3, pages 409-422.
Crossref
Crossref
Nina Rogenhofer, Arseni Markoff, Annett Wagner, Hanns-Georg Klein, David Petroff, Ekkehard Schleussner & Christian J. Thaler. (2016) Lessons From the EThIGII Trial. Clinical and Applied Thrombosis/Hemostasis 23:1, pages 27-33.
Crossref
Crossref
Myrthe van Dijk, Madelon van Wely & Mariëtte Goddijn. 2017. Early Pregnancy. Early Pregnancy
159
168
.
Reshama Navathe & Michela Villani. 2016. Obstetric Evidence Based Guidelines. Obstetric Evidence Based Guidelines
183
192
.
Salvatore Mastrolia, Lena Novack, Jecko Thachil, Anat Rabinovich, Oleg Pikovsky, Vered Klaitman, Giuseppe Loverro & Offer Erez. (2017) LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. Thrombosis and Haemostasis 116:11, pages 868-878.
Crossref
Crossref
Nayoung Sung, Joanne Kwak-Kim, H. S. Koo & K. M. Yang. (2016) Serum hCG-β levels of postovulatory day 12 and 14 with the sequential application of hCG-β fold change significantly increased predictability of pregnancy outcome after IVF-ET cycle. Journal of Assisted Reproduction and Genetics 33:9, pages 1185-1194.
Crossref
Crossref
Tianyi Zhang, Xiaofei Ye, Tiantian Zhu, Xiang XIAO, Yuzhou Liu, Xin Wei, Yu Liu, Cheng Wu, Rui Guan, Xiao Li, Xiaojing Guo, Huili Hu & Jia He. (2015) Antithrombotic Treatment for Recurrent Miscarriage. Medicine 94:45, pages e1732.
Crossref
Crossref
Ekkehard SchleussnerGabriele KaminGregor SeligerNina RogenhoferSusanne EbnerBettina TothMichael SchenkMelanie HenesMichael K. BohlmannThorsten FischerOana BrosteanuRupert BauersachsDavid Petroff. (2015) Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss. Annals of Internal Medicine 162:9, pages 601-609.
Crossref
Crossref
Elisabeth Pasquier, Luc de Saint MartinCaroline BohecCéline ChauleurFlorence BretelleGisèle MarhicGrégoire Le GalVéronique DebargeFrédéric LecomteChristine Denoual-ZiadVéronique Lejeune-SaadaSerge Douvier, Michel Heisert & Dominique Mottier. (2015) Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial. Blood 125:14, pages 2200-2205.
Crossref
Crossref
Carmen Garrido-Gimenez & Jaume Alijotas-Reig. (2015) Recurrent miscarriage: causes, evaluation and management. Postgraduate Medical Journal 91:1073, pages 151-162.
Crossref
Crossref
Lisa Duffett & Marc Rodger. (2015) LMWH to prevent placenta-mediated pregnancy complications: an update. British Journal of Haematology 168:5, pages 619-638.
Crossref
Crossref
Hwa Seon Koo, Joanne Kwak-Kim, Hyun Jeong Yi, Hyun Kyong Ahn, Chan Woo Park, Sun Hwa Cha, Inn Soo Kang & Kwang Moon Yang. (2015) Resistance of Uterine Radial Artery Blood Flow was Correlated with Peripheral Blood NK Cell Fraction and Improved with Low Molecular Weight Heparin Therapy in Women with Unexplained Recurrent Pregnancy Loss. American Journal of Reproductive Immunology 73:2, pages 175-184.
Crossref
Crossref
E. I. Prokopenko, I. G. Nikolskaya, A. V. Vatazin, S. V. Novikova, V. M. Guryeva & A. A. Efanov. (2015) Improvement in pregnancy outcomes with heparin and antiaggregants in patients with various stages of chronic kidney disease. Rossiiskii vestnik akushera-ginekologa 15:5, pages 56.
Crossref
Crossref
Janine E. Polifka & Juliane Habermann. 2015. Drugs During Pregnancy and Lactation. Drugs During Pregnancy and Lactation
225
249
.
Marc A Rodger, William M Hague, John Kingdom, Susan R Kahn, Alan Karovitch, Mathew Sermer, Anne Marie Clement, Suzette Coat, Wee Shian Chan, Joanne Said, Evelyne Rey, Sue Robinson, Rshmi Khurana, Christine Demers, Michael J Kovacs, Susan Solymoss, Kim Hinshaw, James Dwyer, Graeme Smith, Sarah McDonald, Jill Newstead-Angel, Anne McLeod, Meena Khandelwal, Robert M Silver, Gregoire Le Gal, Ian A Greer, Erin Keely, Karen Rosene-Montella, Mark Walker & Philip S Wells. (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. The Lancet 384:9955, pages 1673-1683.
Crossref
Crossref
Mostafa F. Gomaa, Abdellatif G. Elkholy, Mourrad M. El-Said & Nermine E. Abdel-Salam. (2014) Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Archives of Gynecology and Obstetrics 290:4, pages 757-762.
Crossref
Crossref
Paulien G de Jong, Stef Kaandorp, Marcello Di Nisio, Mariëtte Goddijn & Saskia Middeldorp. (2014) Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database of Systematic Reviews 2014:7.
Crossref
Crossref
Alessandro Ghidini. (2014) Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenatal Diagnosis 34:7, pages 649-654.
Crossref
Crossref
Wee-Shian Chan, Evelyne Rey, Nancy E. Kent, Wee-Shian Chan, Nancy E. Kent, Evelyne Rey, Thomas Corbett, Michèle David, M. Joanne Douglas, Paul S. Gibson, Laura Magee, Marc Rodger & Reginald E. Smith. (2014) Venous Thromboembolism and Antithrombotic Therapy in Pregnancy. Journal of Obstetrics and Gynaecology Canada 36:6, pages 527-553.
Crossref
Crossref
Emily Bain, Agnes Wilson, Rebecca Tooher, Simon Gates, Lucy-Jane Davis & Philippa Middleton. (2014) Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Marc A. RodgerMarc CarrierGrégoire Le GalIda MartinelliAnnalisa PernaÉvelyne ReyJ. I. P. de Vries & Jean-Christophe Gris. (2014) Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 123:6, pages 822-828.
Crossref
Crossref
Elisabeth M. Battinelli, Ariela Marshall & Jean M. Connors. (2013) The Role of Thrombophilia in Pregnancy. Thrombosis 2013, pages 1-9.
Crossref
Crossref
Paulien G. de Jong, Mariëtte Goddijn & Saskia Middeldorp. (2013) Antithrombotic therapy for pregnancy loss. Human Reproduction Update 19:6, pages 656-673.
Crossref
Crossref
Jaume Alijotas-Reig & Carmen Garrido-Gimenez. (2013) Current Concepts and New Trends in the Diagnosis and Management of Recurrent Miscarriage. Obstetrical & Gynecological Survey 68:6, pages 445-466.
Crossref
Crossref
Shannon M. Bates. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
627
647
.
Anita Rajasekhar & Marc Zumberg. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
262
290
.
Pablo Alonso-Coello, Shanil Ebrahim, Gordon H Guyatt, Kari AO Tikkinen, Mark H Eckman, Ignacio Neumann, Sarah D McDonald, Elie A Akl & Shannon M Bates. (2012) Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol. BMC Pregnancy and Childbirth 12:1.
Crossref
Crossref
Silvia D'Ippolito, Fiorella Di Nicuolo, Riccardo Marana, Roberta Castellani, John Stinson, Chiara Tersigni, Giovanni Scambia & Nicoletta Di Simone. (2012) Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding–epidermal growth factor and cystein-rich angiogenic inducer 61 expression. Fertility and Sterility 98:4, pages 1028-1036.e2.
Crossref
Crossref
Leif Matthiesen, Satyan Kalkunte & Surendra Sharma. (2012) Multiple Pregnancy Failures: An Immunological Paradigm. American Journal of Reproductive Immunology 67:4, pages 334-340.
Crossref
Crossref
John W. Avery, Geoffrey M. Smith, Simon O. Owino, Demba Sarr, Tamas Nagy, Stephen Mwalimu, James Matthias, Lauren F. Kelly, Jayakumar S. Poovassery, Joab D. Middii, Carlos Abramowsky & Julie M. Moore. (2012) Maternal Malaria Induces a Procoagulant and Antifibrinolytic State That Is Embryotoxic but Responsive to Anticoagulant Therapy. PLoS ONE 7:2, pages e31090.
Crossref
Crossref
Shannon M. Bates, Ian A. Greer, Saskia Middeldorp, David L. Veenstra, Anne-Marie Prabulos & Per Olav Vandvik. (2012) VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy. Chest 141:2, pages e691S-e736S.
Crossref
Crossref
Nicoletta Di Simone, Fiorella Di Nicuolo, Roberta Castellani, Manuela Veglia, Chiara Tersigni, Marco Silano, Alessandra Tritarelli, Giovanni Scambia & Riccardo Marana. (2012) Low-molecular-weight heparins induce decidual heparin-binding epidermal growth factor–like growth factor expression and promote survival of decidual cells undergoing apoptosis. Fertility and Sterility 97:1, pages 169-177.e1.
Crossref
Crossref
I.A. GREER. (2011) Antithrombotic treatment for recurrent pregnancy loss?. Journal of Thrombosis and Haemostasis 9, pages 302-305.
Crossref
Crossref
K. Baumann, D.W. Luedders, K. Diedrich & M.K. Bohlmann. (2011) Mütterliche ThrombophilienMaternal thrombophilia. Der Gynäkologe 44:7, pages 509-514.
Crossref
Crossref
H. Fluhr, J. Spratte, S. Heidrich, J. Ehrhardt, A. Greinacher & M. Zygmunt. (2011) The molecular charge and size of heparins determine their impact on the decidualization of human endometrial stromal cells. Molecular Human Reproduction 17:6, pages 354-359.
Crossref
Crossref
Anna M. Musters, Sjoerd Repping, Johanna C. Korevaar, Sebastiaan Mastenbroek, Jacqueline Limpens, Fulco van der Veen & Mariëtte Goddijn. (2011) Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review of the best available evidence. Fertility and Sterility 95:6, pages 2153-2157.e3.
Crossref
Crossref
E.M. Battinelli & K.A. Bauer. (2011) Thrombophilias in Pregnancy. Hematology/Oncology Clinics of North America 25:2, pages 323-333.
Crossref
Crossref
Jean-Christophe R. Gris. (2011) LMWH have no place in recurrent pregnancy loss: Debate – against the motion. Thrombosis Research 127, pages S110-S112.
Crossref
Crossref
Saskia Middeldorp. (2011) Low-molecular-weight heparins have no place in recurrent miscarriage: Debate – For the motion. Thrombosis Research 127, pages S105-S109.
Crossref
Crossref
Steinburg Pildner von Steinburg & Klaus Marzusch. 2011. Die Geburtshilfe. Die Geburtshilfe
19
32
.
Shannon M. Bates. (2010) Consultative Hematology: The Pregnant Patient Pregnancy Loss. Hematology 2010:1, pages 166-172.
Crossref
Crossref
Peter ClarkIsobel D. WalkerPeter LanghorneLena CrichtonAndrew ThomsonMike GreavesSonia Whyte & Ian A. Greer. (2010) SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 115:21, pages 4162-4167.
Crossref
Crossref
Rebecca Tooher, Simon Gates, Therese Dowswell & Lucy-Jane Davis. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Herbert Fluhr, Julia Spratte, Jens Ehrhardt, Frauke Steinmüller, Peter Licht & Marek Zygmunt. (2010) Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells. Fertility and Sterility 93:8, pages 2581-2587.
Crossref
Crossref
Stef P. Kaandorp, Mariëtte Goddijn, Joris A.M. van der Post, Barbara A. Hutten, Harold R. Verhoeve, Karly Hamulyák, Ben Willem Mol, Nienke Folkeringa, Marleen Nahuis, Dimitri N.M. Papatsonis, Harry R. Büller, Fulco van der Veen & Saskia Middeldorp. (2010) Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage. New England Journal of Medicine 362:17, pages 1586-1596.
Crossref
Crossref
Diana L. Cochran-Black. (2010) Recurrent Pregnancy Loss and Infertility in an Apparently Healthy 23-Year-Old Woman. Laboratory Medicine 41:3, pages 132-134.
Crossref
Crossref
S. MANTHA, K.A. BAUER & J.I. ZWICKER. (2010) Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. Journal of Thrombosis and Haemostasis 8:2, pages 263-268.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:6, pages 470-480.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Pulmonary Medicine 15:5, pages 521-527.
Crossref
Crossref
Giuseppe Camporese & Enrico Bernardi. (2009) Low-molecular-weight heparin for thromboprophylaxis. Current Opinion in Pulmonary Medicine 15:5, pages 443-454.
Crossref
Crossref
Joanne Kwak-Kim, Kwang Moon Yang & Alice Gilman-Sachs. (2009) Recurrent pregnancy loss: A disease of inflammation and coagulation. Journal of Obstetrics and Gynaecology Research 35:4, pages 609-622.
Crossref
Crossref
M.K. Bohlmann, D.W. Luedders, J. Weichert, K. Baumann, M. Thill, K. Diedrich, E. Schleussner & A. Hornemann. (2009) Thrombophile Gerinnungsstörungen als Risikofaktoren für habituelle AborteThrombophilic coagulation disorders as risk factors for recurrent spontaneous abortions. Der Gynäkologe 42:1, pages 17-24.
Crossref
Crossref